We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PBFS:NASDAQPioneer Bancorp, Inc. Analysis

Data as of 2026-06-05 - not real-time

$16.14

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Pioneer Bancorp’s shares are trading at $16.14, comfortably above the 20‑day ($15.04), 50‑day ($14.48) and 200‑day ($13.80) moving averages, signaling a strong bullish trend. The RSI of 61.6 confirms momentum without being overbought, while a bullish MACD (line above signal, positive histogram) adds further technical support. Price sits near the identified resistance of $17.04 with a solid support cushion at $14.20, and despite a decreasing volume trend, the market’s Extreme Greed sentiment (fear‑greed index 92.93) is driving price momentum. Fundamentally, the bank posted an 8.3% revenue growth and healthy operating (24.9%) and profit margins (20.9%), backed by a robust cash position ($165M) and negligible debt. However, the current price exceeds the DCF‑derived fair value of $14.24 and trades at a PE of 19.7, above the industry average of 17.0, indicating a degree of overvaluation. With low beta (0.52), modest volatility (35.7% 30‑day), and no dividend, the stock presents a mixed case: solid fundamentals but limited upside upside until valuation aligns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages
  • Bullish MACD and RSI in the 60s
  • Current price near resistance and above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Overvaluation relative to peers (PE above industry)
  • Strong earnings margins and cash cushion
  • Potential pull‑back toward DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable revenue growth and solid profitability
  • Low leverage and ample liquidity
  • Opportunity to acquire shares at a discount if price reverts to fair value

Key Metrics & Analysis

Financial Health

Revenue Growth8.30%
Profit Margin20.99%
P/E Ratio19.7
ROE6.20%
ROA0.92%
P/B Ratio1.2
Op. Cash Flow$14.5M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI61.6
Support$14.20
Resistance$17.04
MA 20$15.04
MA 50$14.48
MA 200$13.80
MACDBullish
VolumeDecreasing
Fear & Greed Index92.93

Valuation

Fair Value$14.24
GradeOvervalued
TypeValue

Risk Assessment

Beta0.52
Volatility35.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.